Sameer S Kadri1, Junfeng Sun1, Alexander Lawandi1, Jeffrey R Strich2, Lindsay M Busch3, Michael Keller1, Ahmed Babiker4, Christina Yek1, Seidu Malik1, Janell Krack1, John P Dekker5, Alicen B Spaulding6, Emily Ricotta5, John H Powers Iii7, Chanu Rhee8, Michael Klompas8, Janhavi Athale9, Tegan K Boehmer10, Adi V Gundlapalli11, William Bentley12, S Deblina Datta11, Robert L Danner1, Cumhur Y Demirkale1, Sarah Warner1. 1. National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S.W.). 2. National Institutes of Health Clinical Center, Bethesda, Maryland, and U.S. Public Health Service, Rockville, Maryland (J.R.S.). 3. National Institutes of Health Clinical Center, Bethesda, Maryland, and Emory University School of Medicine, Atlanta, Georgia (L.M.B.). 4. Emory University School of Medicine, Atlanta, Georgia (A.B.). 5. National Institute of Allergy and Infectious Diseases, Bethesda, Maryland (J.P.D., E.R.). 6. Children's Minnesota Research Institute, Minneapolis, Minnesota (A.B.S.). 7. Frederick National Laboratory for Cancer Research, Frederick, Maryland (J.H.P.). 8. Brigham and Women's Hospital, Harvard Medical School, and Harvard Pilgrim Health Care Institute, Boston, Massachusetts (C.R., M.K.). 9. National Institutes of Health Clinical Center, Bethesda, Maryland, and Mayo Clinic Arizona, Phoenix, Arizona (J.A.). 10. U.S. Public Health Service, Rockville, Maryland, and Centers for Disease Control and Prevention, Atlanta, Georgia (T.K.B.). 11. Centers for Disease Control and Prevention, Atlanta, Georgia (A.V.G., S.D.D.). 12. Centers for Disease Control and Prevention, Atlanta, Georgia, and General Dynamics Information Technology, Falls Church, Virginia (W.B.).
Abstract
BACKGROUND: Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. OBJECTIVE: To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. DESIGN: Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). SETTING: 558 U.S. hospitals in the Premier Healthcare Database. PARTICIPANTS: Adult COVID-19-coded inpatients admitted from March to August 2020 with discharge dispositions by October 2020. MEASUREMENTS: Each hospital-month was stratified by percentile rank on a surge index (a severity-weighted measure of COVID-19 caseload relative to pre-COVID-19 bed capacity). The effect of surge index on risk-adjusted odds ratio (aOR) of in-hospital mortality or discharge to hospice was calculated using hierarchical modeling; interaction by surge attributes was assessed. RESULTS: Of 144 116 inpatients with COVID-19 at 558 U.S. hospitals, 78 144 (54.2%) were admitted to hospitals in the top surge index decile. Overall, 25 344 (17.6%) died; crude COVID-19 mortality decreased over time across all surge index strata. However, compared with nonsurging (<50th surge index percentile) hospital-months, aORs in the 50th to 75th, 75th to 90th, 90th to 95th, 95th to 99th, and greater than 99th percentiles were 1.11 (95% CI, 1.01 to 1.23), 1.24 (CI, 1.12 to 1.38), 1.42 (CI, 1.27 to 1.60), 1.59 (CI, 1.41 to 1.80), and 2.00 (CI, 1.69 to 2.38), respectively. The surge index was associated with mortality across ward, intensive care unit, and intubated patients. The surge-mortality relationship was stronger in June to August than in March to May (slope difference, 0.10 [CI, 0.033 to 0.16]) despite greater corticosteroid use and more judicious intubation during later and higher-surging months. Nearly 1 in 4 COVID-19 deaths (5868 [CI, 3584 to 8171]; 23.2%) was potentially attributable to hospitals strained by surging caseload. LIMITATION: Residual confounding. CONCLUSION: Despite improvements in COVID-19 survival between March and August 2020, surges in hospital COVID-19 caseload remained detrimental to survival and potentially eroded benefits gained from emerging treatments. Bolstering preventive measures and supporting surging hospitals will save many lives. PRIMARY FUNDING SOURCE: Intramural Research Program of the National Institutes of Health Clinical Center, the National Institute of Allergy and Infectious Diseases, and the National Cancer Institute.
BACKGROUND: Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. OBJECTIVE: To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19mortality risk and identify effect modifiers of this relationship. DESIGN: Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). SETTING: 558 U.S. hospitals in the Premier Healthcare Database. PARTICIPANTS: Adult COVID-19-coded inpatients admitted from March to August 2020 with discharge dispositions by October 2020. MEASUREMENTS: Each hospital-month was stratified by percentile rank on a surge index (a severity-weighted measure of COVID-19 caseload relative to pre-COVID-19 bed capacity). The effect of surge index on risk-adjusted odds ratio (aOR) of in-hospital mortality or discharge to hospice was calculated using hierarchical modeling; interaction by surge attributes was assessed. RESULTS: Of 144 116 inpatients with COVID-19 at 558 U.S. hospitals, 78 144 (54.2%) were admitted to hospitals in the top surge index decile. Overall, 25 344 (17.6%) died; crude COVID-19mortality decreased over time across all surge index strata. However, compared with nonsurging (<50th surge index percentile) hospital-months, aORs in the 50th to 75th, 75th to 90th, 90th to 95th, 95th to 99th, and greater than 99th percentiles were 1.11 (95% CI, 1.01 to 1.23), 1.24 (CI, 1.12 to 1.38), 1.42 (CI, 1.27 to 1.60), 1.59 (CI, 1.41 to 1.80), and 2.00 (CI, 1.69 to 2.38), respectively. The surge index was associated with mortality across ward, intensive care unit, and intubated patients. The surge-mortality relationship was stronger in June to August than in March to May (slope difference, 0.10 [CI, 0.033 to 0.16]) despite greater corticosteroid use and more judicious intubation during later and higher-surging months. Nearly 1 in 4 COVID-19 deaths (5868 [CI, 3584 to 8171]; 23.2%) was potentially attributable to hospitals strained by surging caseload. LIMITATION: Residual confounding. CONCLUSION: Despite improvements in COVID-19 survival between March and August 2020, surges in hospital COVID-19 caseload remained detrimental to survival and potentially eroded benefits gained from emerging treatments. Bolstering preventive measures and supporting surging hospitals will save many lives. PRIMARY FUNDING SOURCE: Intramural Research Program of the National Institutes of Health Clinical Center, the National Institute of Allergy and Infectious Diseases, and the National Cancer Institute.
Authors: Christianne Joy Lane; Manas Bhatnagar; Karen Lutrick; Ryan C Maves; Debra Weiner; Daisy Rios Olvera; Timothy M Uyeki; J Perren Cobb; Joan C Brown Journal: Crit Care Explor Date: 2022-01-05
Authors: Geoffrey P Whitfield; Aaron M Harris; Sameer S Kadri; Sara Warner; Sapna Bamrah Morris; Jennifer E Giovanni; Jessica S Rogers-Brown; Alison F Hinckley; Lyudmyla Kompaniyets; Kanta D Sircar; Hussain R Yusuf; Emilia H Koumans; Beth K Schweitzer Journal: Open Forum Infect Dis Date: 2021-11-30 Impact factor: 3.835
Authors: Laurent G Glance; Andrew W Dick; Ernie Shippey; Patrick J McCormick; Richard Dutton; Patricia W Stone; Jingjing Shang; Stewart J Lustik; Heather L Lander; Igor Gosev; Karen E Joynt Maddox Journal: JAMA Netw Open Date: 2022-07-01
Authors: Kate Christensen; Mitch Metzner; LeAnne Lovett-Floom; Carol Lindsay; Colin A Meghoo; Kathy Staats; Asha Devereaux; Erin Noste; Howard Backer Journal: Disaster Med Public Health Prep Date: 2022-04-01 Impact factor: 5.556
Authors: Pratik Sinha; David Furfaro; Matthew J Cummings; Darryl Abrams; Kevin Delucchi; Manoj V Maddali; June He; Alison Thompson; Michael Murn; John Fountain; Amanda Rosen; Shelief Y Robbins-Juarez; Matthew A Adan; Tejus Satish; Mahesh Madhavan; Aakriti Gupta; Alexander K Lyashchenko; Cara Agerstrand; Natalie H Yip; Kristin M Burkart; Jeremy R Beitler; Matthew R Baldwin; Carolyn S Calfee; Daniel Brodie; Max R O'Donnell Journal: Am J Respir Crit Care Med Date: 2021-12-01 Impact factor: 21.405
Authors: Jeffrey R Dichter; Asha V Devereaux; Charles L Sprung; Vikramjit Mukherjee; Jason Persoff; Karyn D Baum; Douglas Ornoff; Amit Uppal; Tanzib Hossain; Kiersten N Henry; Marya Ghazipura; Kasey R Bowden; Henry J Feldman; Mitchell T Hamele; Lisa D Burry; Anne Marie O Martland; Meredith Huffines; Pritish K Tosh; James Downar; John L Hick; Michael D Christian; Ryan C Maves Journal: Chest Date: 2021-09-06 Impact factor: 9.410